FNDX vs VHT
Schwab Fundamental US Large Company Index ETF vs Vanguard Health Care ETF
- • VHT has the lower expense ratio at 0.09% vs 0.25% for FNDX.
- • VHT pays a higher dividend yield (1.72%).
Side-by-side metrics
| Metric | FNDX | VHT |
|---|---|---|
Expense ratio Annual fee. Lower is better. | 0.25% | 0.09% |
Dividend yield Trailing 12-month yield. | 1.50% | 1.72% |
AUM Assets under management — bigger funds are typically more liquid. | $25.91B | $18.51B |
YTD return | 12.17% | -4.77% |
1-year return | — | — |
3-year return Annualized. | — | — |
5-year return Annualized. | — | — |
10-year return Annualized. | — | — |
Beta (3Y) Volatility relative to the market. Closer to 1 = market-like. | 0.86 | 0.64 |
P/E ratio | 20.94 | 25.44 |
Last price | $30.16 | $271.09 |
Inception | — | — |
Issuer | Schwab | Vanguard |
FNDX top holdings
| AAPL | Apple Inc | 4.18% |
| XOM | Exxon Mobil Corp | 2.54% |
| MSFT | Microsoft Corp | 2.28% |
| GOOGL | Alphabet Inc Class A | 2.28% |
| INTC | Intel Corp | 2.21% |
| AMZN | Amazon.com Inc | 1.88% |
| GOOG | Alphabet Inc Class C | 1.82% |
| CVX | Chevron Corp | 1.63% |
| JPM | JPMorgan Chase & Co | 1.49% |
| BRK-B | Berkshire Hathaway Inc Class B | 1.47% |
VHT top holdings
| LLY | Eli Lilly and Co | 11.89% |
| JNJ | Johnson & Johnson | 9.34% |
| ABBV | AbbVie Inc | 6.18% |
| MRK | Merck & Co Inc | 4.80% |
| UNH | UnitedHealth Group Inc | 3.94% |
| AMGN | Amgen Inc | 3.05% |
| TMO | Thermo Fisher Scientific Inc | 2.97% |
| ABT | Abbott Laboratories | 2.87% |
| GILD | Gilead Sciences Inc | 2.78% |
| ISRG | Intuitive Surgical Inc | 2.63% |
About FNDX
FNDX (Schwab Fundamental US Large Company Index ETF) is US large caps weighted by fundamental factors. Managed by Schwab, the fund carries $25.9B in assets under management, an expense ratio of 0.25%, a dividend yield of 1.50%. Its largest holding is Apple Inc (AAPL), which represents 4.2% of the portfolio. Real Estate is the fund's largest sector exposure at 1.8%.
About VHT
VHT (Vanguard Health Care ETF) is US health care sector stocks. Managed by Vanguard, the fund carries $18.5B in assets under management, an expense ratio of 0.09%, a dividend yield of 1.72%. Its largest holding is Eli Lilly and Co (LLY), which represents 11.9% of the portfolio. Technology is the fund's largest sector exposure at 0.0%.